by Elena Iemma | Jan 22, 2025 | Blog
Regulatory T Cells and Immune Tolerance in Biologic Drug Development The recent Nobel Prize recognition of discoveries in immune tolerance highlights how far regulatory T cell biology has progressed, from foundational immunology to active therapeutic development....
by Elena Iemma | Jan 22, 2025 | Blog
Applying Immunoinformatics to Animal Health We were thrilled to have a visit by Julia Baker (U of Minn Vet School) last week! She gave a terrific talk to the Epi-team on the evolution of Porcine Reproductive and Respiratory Syndrome virus...
by Elena Iemma | Dec 28, 2024 | Events, Featured
Tentative date: June 5 & 6, 2025 9:00am – 5:00pm (with receptions to follow!) 350 Eddy St. Providence, RI 02903 Save the Date The second Artificial Intelligence / Human Intelligence Workshop is tentatively planned for June 5 and 6th at the South Street...
by Elena Iemma | Dec 19, 2024 | Blog
Even more Fearless in 2025 2024 was a year of transformation and momentum for us—a real steppingstone to EpiVax 2.0. We are grateful to our new CEO, Rich-Henry Schabowsky, for creating a work environment where innovation moves...
by Elena Iemma | Dec 9, 2024 | News
EpiVax Drives Immunogenicity Innovation in 2024: Year in Review PROVIDENCE, R.I., Dec. 6, 2024 — EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by...
